Eli Lilly and Co. said Thursday a drug regimen including its Alimta therapy did not improve the survival of lung cancer patients in a ...

Testing for specific cancer protein markers in lung cancer patients' blood helps find those more likely to respond to Tarceva, a drug so...

Lung cancer patients whose tumors over-express a cell surface molecule called CXCR4 do significantly worse than those who do not, Canadian r...

Celator Pharmaceuticals today announced data from animal studies demonstrating the superior bone marrow uptake of CPX-351 (Cytarabine:Daunor...

Women at high risk can take either drug as preventive therapy, researchers in a seven-year study say. Two drugs taken by women at high risk ...

The cancer drug cyclophosphamide activates a viral infection that helps anti-viral medications eliminate a virus-linked cancer, says a new s...

Researchers announced positive results from tests of an experimental anti-cancer drug known as NGR-hTNF in controlling the cancer of patient...

Azaya Therapeutics, Inc. announced today that the Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) applica...

Medications frequently given to cancer patients to reduce their risk of anemia are associated with an increased risk of deep vein thrombosis...

A drug previously approved for the treatment of non-Hodgkin’s B cell lymphoma and rheumatoid arthritis, can treat severe ANCA-associated vas...

A new drug designed to “seek and destroy” common cancers such as breast, prostate, endometrial, pancreatic, ovarian, skin and testicular can...

Drugs made using unusual metals could form an effective treatment against colon and ovarian cancer, including cancerous cells that have deve...

Spectrum Pharmaceuticals said U.S. health regulators declined to approve its supplementary marketing application for its advanced metastatic...

GenSpera, Inc. announced today that the Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application to be...

An experimental cancer drug that switches off the so-called "Hedgehog" pathway beat back tumors in more than half of patients with...

The team of investigators, led by faculty members Li Yu, Ph.D., and Jianjun Cheng, Ph.D., M.S., who is also a member of the Siteman Center o...

Researchers of different Boston-area institutions recently discovered a chemical that worked in mice to kill aggressive cells within breast ...

Immunomedics, Inc. , a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, tod...

AVEO Pharmaceuticals, Inc., a biopharmaceutical company leveraging breakthrough discoveries in cancer biology to discover, develop and comme...

Nanoparticles that can carry cancer-killing radioisotopes directly to tumors show promise, U.S. researchers report. The nanoparticles are ma...